|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 56.03 USD | -0.16% |
|
-4.24% | -5.72% |
| 11-03 | BioMarin Likely Able to Support New Prospects, Wedbush Says | MT |
| 11-03 | Oppenheimer Adjusts BioMarin Pharmaceutical PT to $94 From $97, Maintains Outperform Rating | MT |
| Market Cap | 10.85B 9.73B 8.9B 8.12B 15.3B 1,020B 15.78B 107B 42.76B 544B 40.74B 39.86B 1,718B | P/E 2026 * |
79x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 13.7B 12.29B 11.23B 10.25B 19.31B 1,288B 19.92B 135B 53.97B 687B 51.42B 50.32B 2,169B | EV / Sales 2026 * |
3.54x | EV / Sales 2027 * | 2.88x |
| Free-Float |
99.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BMRN | Delayed | |
CBOE
| BMRN | Real-time | |
|
London S.E.
| 0HNC | Delayed | |
|
Tradegate
| BM8 | Real-time | |
|
Wiener Boerse
| BMRN | End-of-day quote | |
|
Deutsche Boerse AG
| BM8 | Delayed | |
|
Berne S.E.
| BM8 | End-of-day quote | |
|
Mexican S.E.
| BMRN * | End-of-day quote | |
|
Börse Stuttgart
| BM8 | Delayed | |
|
Boerse Muenchen
| BM8 | Real-time | |
|
Borsa Italiana
| 1BMRN | End-of-day quote |
Last Transcript: BioMarin Pharmaceutical Inc.
| 1 day | -0.16% | ||
| 1 week | -4.24% | ||
| Current month | -4.24% | ||
| 1 month | -0.34% | ||
| 3 months | -8.84% | ||
| 6 months | +2.62% | ||
| Current year | -5.72% |
| 1 week | 52 |  | 59.51 |
| 1 month | 52 | | 59.51 |
| Current year | 49.26 | | 70.98 |
| 1 year | 49.26 | | 70.98 |
| 3 years | 49.26 | | 99.56 |
| 5 years | 49.26 | | 117.77 |
| 10 years | 49.26 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 2020-01-28 |
Arpit Davé
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Willard Dere
BRD | Director/Board Member | 72 | 2016-07-17 |
Robert Hombach
BRD | Director/Board Member | 60 | 2017-09-28 |
| Director/Board Member | 69 | 2019-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Tax | Chief Technology Officer | -4,086 | 0.0021% | ||
| 9/10/26 | Free | Director | 6,140 | 0.0032% | ||
| 9/2/26 | Sell | General Counsel | -17,557 | 0.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.16% | -4.24% | +8.08% | -26.49% | 10.87B | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 293B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | |
| Average | -0.09% | -0.76% | +37.17% | +66.26% | 419.87B | |
| Weighted average by Cap. | -0.05% | -1.22% | +42.11% | +88.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.87B 3.47B 3.17B 2.9B 5.46B 364B 5.63B 38.24B 15.25B 194B 14.53B 14.22B 613B | 4.46B 4B 3.65B 3.34B 6.28B 419B 6.48B 44.04B 17.56B 224B 16.73B 16.37B 706B |
| Net income | 118M 106M 96.43M 88.02M 166M 11.06B 171M 1.16B 463M 5.9B 442M 432M 18.63B | 851M 763M 698M 637M 1.2B 80B 1.24B 8.41B 3.35B 42.69B 3.19B 3.13B 135B |
| Net Debt | 2.85B 2.55B 2.33B 2.13B 4.01B 268B 4.14B 28.12B 11.21B 143B 10.68B 10.45B 451B | 1.98B 1.78B 1.62B 1.48B 2.79B 186B 2.88B 19.56B 7.8B 99.27B 7.43B 7.27B 313B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$56.03 | -0.16% | 2,733,261 |
| 26-11-05 | US$56.12 | -1.77% | 2,164,801 |
| 26-11-04 | US$57.13 | +2.64% | 3,223,294 |
| 26-11-03 | US$55.66 | -3.10% | 4,698,502 |
| 26-11-02 | US$57.44 | -1.83% | 3,264,552 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
